WARREN, N.J., June 9, 2017 /PRNewswire/ -- Roka
Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company
focused on providing advanced testing solutions for the detection
of foodborne pathogens, today announced that Mary Duseau, CEO will present at the 2017 MARCUM
MICROCAP CONFERENCE on June 16,
2017 at 10:30am ET. The
conference will be held at The Grand Hyatt New York.
During this presentation, material information concerning the
Company, its operations, strategies and prospects may be discussed.
To listen to the audio webcast of the presentation during the
event, please visit: http://rokabio.investorroom.com/. A replay of
the webcast will be available for 10 days after the
presentation.
The Marcum MicroCap Conference (www.marcummicrocap.com) is a
nationally recognized forum for publicly traded companies with less
than $500 million in market
capitalization to network with fund managers and high net worth
investors who focus on small cap equities. More than 2000 investors
and other participants from every segment of the microcap
marketplace attend each year, including venture and lower
middle-market private equity investors, institutional investors,
directors, investment bankers, and buy- and sell-side analysts, as
well as senior executive teams from presenting companies and
service providers to the microcap marketplace.
About Roka Bioscience
Roka Bioscience is a molecular diagnostics company focused on
developing and commercializing advanced testing solutions for the
food safety testing market. Our Atlas Detection Assays incorporate
our advanced molecular technologies and are performed on our
"sample-in, result-out" Atlas System that automates all aspects of
molecular diagnostic testing on a single, integrated platform. The
Atlas System and Detection Assays are designed to provide our
customers with accurate and rapid test results with reduced labor
costs and improved laboratory efficiencies. For more
information, visit http://rokabio.com.
Investor Contact:
Roka
Bioscience, Inc.
ir@rokabio.com
855-ROKABIO (855-765-2246)
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/roka-bioscience-to-present-at-the-2017-marcum-microcap-conference-300471806.html
SOURCE Roka Bioscience, Inc.